Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Single-Center, Open-Label Study to Assess the Efficacy and Tolerability of a Brightening Serum in Skin of Color Patients With Post Inflammatory Hyperpigmentation

NCT07896486 is registered in ClinicalTrials.gov with Weill Medical College of Cornell University as lead sponsor.

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, 14-day trial. Card required. Your first charge is when the trial ends. See pricing

Get the NCT07896486 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Follow this trial by email

Registry record

As filed in ClinicalTrials.gov.

Title
A Single-Center, Open-Label Study to Assess the Efficacy and Tolerability of a Brightening Serum in Skin of Color Patients With Post Inflammatory Hyperpigmentation
Lead sponsor
Weill Medical College of Cornell University
Phase
Not applicable
Overall status
Not yet recruiting
Start date
September 30, 2026
Completion date
January 15, 2027
Enrollment
20 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

post-acne hyperpigmentation, post-inflammatory hyperpigmentation

Arms

As registered; 1 arm.

  • Participants with Acne-Associated Post-Inflammatory Hyperpigmentation using the Vinoperfect Serum OtherVinoperfect brightening serum

    Participants will undergo a standardized twice-daily skincare regimen for 12 weeks. In the morning, participants will cleanse their face, apply the Vinoperfect Brightening Serum, apply moisturizer, and then apply SPF 50+ sunscreen. In the evening, participants will cleanse their face, apply the Vinoperfect Brightening Serum, and apply moisturizer.

Primary endpoints

Registered primary outcome measures; 1 primary.

  • Change from baseline in PIH of the face at Week 12, as assessed by the Post-Acne Hyperpigmentation Index (PAHPI) score Baseline; 12 weeks

    Total scores on the PAHPI range from 6 to 22, with higher scores indicating greater severity of post-acne hyperpigmentation

Lead sponsor's other trials

Weill Medical College of Cornell University, most recent start first.

Similar trials

Same condition (Hyperpigmentation) and phase, most recent start first.